33.2 C
Delhi
Monday, September 8, 2025

Alembic Pharma receives USFDA final approval for Fluorouracil Injection

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Alembic Pharma on Monday said it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Fluorouracil Injection, 2.5 g/50 mL (50 mg/mL), of Spectrum Pharmaceuticals, Inc. (Spectrum). Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum, adenocarcinoma of the breast, gastric adenocarcinoma and pancreatic adenocarcinoma. Refer to our label for full indication.

Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Vial, has an estimated market size of US$ 5 million for twelve months ending Dec 2022 according to IQVIA.

Related articles

Stricter US visa rules make renewals tough for Indians working or studying in the US

New Delhi: Indians studying or working in the US are a worried lot, amid the new visa rules...

India stands united to overcome global challenges: Piyush Goyal

New Delhi: Commerce and Industry Minister Piyush Goyal today said that no matter how big the problem arises...

Delhi police bust infant trafficking ring, arrest ten and rescue six children

New Delhi: The Delhi Police on Monday busted a human trafficking gang and arrested ten of its members...

NC demands police probe into the ‘misuse’ of the national emblem at Hazratbal by J&K Waqf

Srinagar: The controversy over the alleged defacing of the national emblem at the revered Hazratbal shrine refuses to...